Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
为应对 COVID-19疫情的爆发，北京博奥森生物技术有限公司启动了针对新型冠状病毒的科研攻关，成功研发出SARS-CoV-2 (2019-nCoV) Nucleoprotein蛋白检测试剂盒。  该试剂盒根据ELISA双抗体夹心法原理，采用一步法，实现对2019-nCoV抗原蛋白的快速准确检测。试剂盒所采用原料均来自本公司科研团队自主研发，经严苛筛选验证，保证其灵敏度高、特异性好，结果一致且可靠，为疫情的相关疫苗及治疗性药物研究等工作贡献一份力量。

产品特色：
1 时间短，提高检测效率；
2 操作简便，实验误差更小；
3 样本需求量小，节约珍贵检测样本；
4 灵敏度高及特异性好，结果一致且可靠。
Important Note：This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.